🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of the study is to evaluate the change in liver copper (...
Status
Completed
Location
Research Site
Start Date
2020-12-02
Trial ID
NCT04422431
Treatments Being Tested
This is a Phase 1, randomized, 2-period, 2-sequence, cross-over study desig...
Status
Completed
Location
Clinical Trial Site
Start Date
2020-10-21
Trial ID
NCT04526210
Treatments Being Tested
This is an open-label, single-arm, multi-center EAP, designed to provide ea...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05686564
Treatments Being Tested
The study will assess the relative bioavailability of 2 different formulati...
Status
Completed
Location
Nucleus Network Pty Ltd.
Start Date
2021-01-31
Trial ID
NCT04610580
Treatments Being Tested
This study will evaluate the effect of a supratherapeutic dose of ALXN1840 ...
Status
Completed
Location
PPD Development, LP
Start Date
2020-07-24
Trial ID
NCT04560816
Treatments Being Tested
This was single-center, open-label, randomized, 3-period, 3-treatment, 6-se...
Status
Completed
Location
Clinical Trial Site
Start Date
2014-04-07
Trial ID
NCT05319912
Treatments Being Tested
This was single-center, open-label, randomized, 3-period, 3-treatment, 6-se...
Status
Completed
Location
Clinical Trial Site
Start Date
2014-01-20
Trial ID
NCT05319899
Treatments Being Tested
The study will evaluate the efficacy and safety of ALXN1840 (formerly calle...
Status
Terminated
Location
Research Site
Start Date
2018-02-22
Trial ID
NCT03403205
Treatments Being Tested
To assess the relative bioavailability of ALXN1840 administered orally as a...
Status
Completed
Location
Clinical Trial Site
Start Date
2019-07-04
Trial ID
NCT05303324
Treatments Being Tested